BioNTech SE (BNTX)
110.34
+3.72
(+3.49%)
USD |
NASDAQ |
Feb 09, 16:00
111.12
+0.78
(+0.71%)
After-Hours: 20:00
BioNTech EPS Diluted (Quarterly) : -0.1395 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CureVac NV | 1.414 |
| Novavax, Inc. | -1.246 |
| Pfizer Inc. | -0.2898 |
| Sanofi | -- |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -33.54M |
| Revenue (Quarterly) | 1.775B |
| Total Expenses (Quarterly) | 1.809B |
| Enterprise Value | 11.08B |
| Gross Profit Margin (Quarterly) | 90.24% |
| Profit Margin (Quarterly) | -1.89% |
| Earnings Yield | -2.38% |
| Normalized Earnings Yield | -2.743 |